BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17018759)

  • 21. Cannabinoids in Patients with Nausea and Vomiting Associated with Malignancy and Its Treatments.
    Garcia JM; Shamliyan TA
    Am J Med; 2018 Jul; 131(7):755-759.e2. PubMed ID: 29909841
    [No Abstract]   [Full Text] [Related]  

  • 22. [ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting].
    Longo F; Mansueto G; Magnolfi E
    Tumori; 2006; 92(1):suppl 24-31. PubMed ID: 16683393
    [No Abstract]   [Full Text] [Related]  

  • 23. [Medical treatment of chemotherapy-induced nausea and vomiting].
    Herrstedt J
    Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents].
    Eliasen A; Callesen MT; Dalhoff KP; Rechnitzer C; Schmiegelow K; Schrøder H; Tuckuviene R; Holst H
    Ugeskr Laeger; 2018 Aug; 180(35):. PubMed ID: 30152323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.
    National Comprehensive Cancer Network (NCCN)
    J Support Oncol; 2004; 2(4):366. PubMed ID: 15357520
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of chemotherapy-induced side-effects.
    Raji MA
    Lancet Oncol; 2005 Jun; 6(6):357. PubMed ID: 15925813
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of nausea and vomiting caused by cancer chemotherapy.
    Laszlo J
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():3-9. PubMed ID: 6299552
    [No Abstract]   [Full Text] [Related]  

  • 29. Corticosteroids in the treatment of chemotherapy-induced nausea and vomiting.
    Barbour SY
    J Natl Compr Canc Netw; 2012 Apr; 10(4):493-9. PubMed ID: 22491048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should anaesthetists be giving dexamethasone to patients with malignancy?
    Hoyle J; Williams A
    Br J Hosp Med (Lond); 2011 Aug; 72(8):478. PubMed ID: 21841601
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of vomiting induced by cytostatic agents].
    Díaz-Rubio E
    Med Clin (Barc); 1989 Jun; 93(2):54-7. PubMed ID: 2666781
    [No Abstract]   [Full Text] [Related]  

  • 32. [Position statement of the (Hungarian) College of Oncology and Radiotherapy regarding the health insurance reimbursement for Emend(aprepitant)].
    Pikó B;
    Magy Onkol; 2009 Mar; 53(1):81-2. PubMed ID: 19318331
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of Navoban for managing nausea and vomiting during the aggressive chemotherapy of malignant neoplasms].
    Seliuzhitskiĭ IV; Eliseev SN
    Voen Med Zh; 1993 Oct; (10):35-6. PubMed ID: 8303850
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of Navoban in pediatric oncology].
    Safonova SA; Kolygin BA; Punanov IA; Borodina AF
    Vopr Onkol; 1996; 42(6):72-3. PubMed ID: 9123909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP; Taggart JR; Bender CM
    Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locally derived clinical practice guidelines using a decision analysis model.
    Mutnick AH; Szymusiak-Mutnick BA
    AACN Clin Issues; 1996 Aug; 7(3):448-55. PubMed ID: 8826406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [1 year's use of alizapride for the prevention and treatment of nausea and vomiting secondary to anticancer agents].
    Olivier JP
    Ann Gastroenterol Hepatol (Paris); 1985 Jan; 21(1):53-5. PubMed ID: 3977279
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention and treatment of nausea and vomiting induced by chemotherapy. Introduction].
    Schittulli F
    Tumori; 2008; 94(2):suppl 1-5. PubMed ID: 18564619
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
    Oo TH; Hesketh PJ
    Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.